Ginkgo Bioworks Holdings Inc vs Microchip Technology Inc. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $590.53M), while Microchip Technology Inc. trades at $88.54 (market cap $47.30B). The key difference: Microchip Technology Inc. is far larger — about 80.1× Ginkgo Bioworks Holdings Inc's market cap, and Microchip Technology Inc. pays a 2.09% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | MCHP | |
|---|---|---|
Market Cap | $590.53M | $47.30B |
Sector | Health | Technology |
52-Week High | $16.14 | $102.97 |
52-Week Low | $5.48 | $49.02 |
Enterprise Value | $627.78M | $52.60B |
Dividend Yield | — | 2.09% |
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →